Marzena Kucharczyk

Marzena Kucharczyk

Auto-generated profile, based on publicly available information

Marzena Kucharczyk

Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2012 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
AJAleksandra Jezela-Stanek
Aleksandra Jezela-Stanek
MKMarzena Kucharczyk
Marzena Kucharczyk
MPMagdalena Pelc
Magdalena Pelc
KCKrystyna Chrzanowska
Krystyna Chrzanowska
MKMałgorzata Krajewska-Walasek
Małgorzata Krajewska-Walasek

30 March 2016 in Biomedical Papers
Verified
Journal Article
Open access
PDF file
AJAleksandra Jezela-Stanek
Aleksandra Jezela-Stanek
MKMarzena Kucharczyk
Marzena Kucharczyk
KFKatarzyna Falana
Katarzyna Falana
DJDorota Jurkiewicz
Dorota Jurkiewicz
MMMarlena Mlynek
Marlena Mlynek
MKMałgorzata Krajewska-Walasek
Małgorzata Krajewska-Walasek
Sotos syndrome 2 (MIM #614753), known also as Malan syndrome, is caused by heterozygous mutations/deletions of the NFIX gene located on chromosome 19p13.2. It manifests in developmental delay, intellectual impairment, macrocephaly, central nervous system anomalies, postnatal overgrowth, and craniofacial dysmorphism. Unusual behavior with/without autistic traits, ophthalmologic, gastrointestinal, musculo-skeletal, and hand/foot abnormalities are also frequent. Due to the limited number of such cases, no definitive conclusions about genotype-phenotype correlations have been possible. In the following paper, we discuss physical features consistent with Sotos syndrome 2 based on literature review and two new cases [a patient with de novo 19p13.2 deletion encompassing a part of the NFIX gene and a patient with de novo (not described so far) heterozygous missense mutation c.367C>T (p.Arg123Trp) in the NFIX gene]. Apart from overgrowth and psychomotor developmental delay, the most consistent physical features of our two patients are dysmorphism including high forehead, downslanting palpebral fissures, pointed chin, and abnormalities of the pinna. Both show abnormal behavior and present with long, tapered fingers and toenail defect. No severe congenital malformations were noted. We hope these data will serve as a material for further studies and provide an opportunity to make more reliable genotype-phenotype correlations.

23 October 2018 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
VPVictor Murcia Pienkowski
Victor Murcia Pienkowski
MKMarzena Kucharczyk
Marzena Kucharczyk
MMMarlena Mlynek
Marlena Mlynek
KSKrzysztof Szczałuba
Krzysztof Szczałuba
MRMałgorzata Rydzanicz
Małgorzata Rydzanicz
RPRafal Ploski
Rafal Ploski
Background: Mapping the breakpoints in de novo balanced chromosomal translocations (BCT) in symptomatic individuals provides a unique opportunity to identify in an unbiased way the likely causative genetic defect and thus find novel human disease candidate genes. Our aim was to fine-map breakpoints of de novo BCTs in a case series of nine patients. Methods: Shallow whole-genome mate pair sequencing (SGMPS) together with long-range PCR and Sanger sequencing. In one case (BCT disrupting BAHD1 and RET) cDNA analysis was used to verify expression of a fusion transcript in cultured fibroblasts. Results: In all nine probands 11 disrupted genes were found, that is, EFNA5, EBF3, LARGE, PPP2R5E, TXNDC5, ZNF423, NIPBL, BAHD1, RET, TRPS1 and SLC4A10. Five subjects had translocations that disrupted genes with so far unknown (EFNA5, BAHD1, PPP2R5E, TXNDC5) or poorly delineated impact on the phenotype (SLC4A10, two previous reports of BCT disrupting the gene). The four genes with no previous disease associations (EFNA5, BAHD1, PPP2R5E, TXNDC5), when compared with all human genes by a bootstrap test, had significantly higher pLI (p<0.017) and DOMINO (p<0.02) scores indicating enrichment in genes likely to be intolerant to single copy damage. Inspection of individual pLI and DOMINO scores, and local topologically associating domain structure suggested that EFNA5, BAHD1 and PPP2R5E were particularly good candidates for novel disease loci. The pathomechanism for BAHD1 may involve deregulation of expression due to fusion with RET promoter. Conclusion: SGMPS in symptomatic carriers of BCTs is a powerful approach to delineate novel human gene–disease associations.

31 March 2016 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MKMałgorzata Krajewska-Walasek
Małgorzata Krajewska-Walasek
DJDorota Jurkiewicz
Dorota Jurkiewicz
DPDorota Piekutowska-Abramczuk
Dorota Piekutowska-Abramczuk
MKMarzena Kucharczyk
Marzena Kucharczyk
KCKrystyna Chrzanowska
Krystyna Chrzanowska
ECElżbieta Ciara
Elżbieta Ciara

19 November 2012 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
AJAleksandra Jezela-Stanek
Aleksandra Jezela-Stanek
MKMarzena Kucharczyk
Marzena Kucharczyk
MPMagdalena Pelc
Magdalena Pelc
AGAnna Gutkowska
Anna Gutkowska
MKMałgorzata Krajewska-Walasek
Małgorzata Krajewska-Walasek

8 August 2014 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MKMarzena Kucharczyk
Marzena Kucharczyk
AKAdam Kochanski
Adam Kochanski
AJAleksandra Jezela‐Stanek
Aleksandra Jezela‐Stanek
MKMonika Kugaudo
Monika Kugaudo
DSDanuta Sielska-Rotblum
Danuta Sielska-Rotblum
MKMałgorzata Krajewska-Walasek
Małgorzata Krajewska-Walasek